Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to test whether Lixisenatide (AVE0010) restores first phase
and improves second phase insulin response in subjects with diabetes mellitus type 2.